Cognitively preserved subjects with transitional cerebrospinal fluid ß-amyloid 1-42 values have thicker cortex in Alzheimer's disease vulnerable areas.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Biological Psychiatry

• Publication date

  2011-07-15

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.biopsych.2011.02.017PMID 21514924
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Apolipoprotein E ε4-related thickening of the cerebral cortex modulates selective attention.

  2012cited by this paper
• Cerebrospinal Fluid Biomarkers and Memory Present Distinct Associations along the Continuum from Healthy Subjects to AD Patients

  2011cited by this paper
• Cerebrospinal Fluid Biomarkers in Alzheimer’s Disease Families with PSEN1 Mutations

  2011cited by this paper
• Acceleration of cortical thinning in familial Alzheimer's disease.

  2011cited by this paper
• Increased Cortical Thickness and Caudate Volume Precede Atrophy in PSEN1 Mutation Carriers

  2010cited by this paper
• APOE predicts amyloid‐beta but not tau Alzheimer pathology in cognitively normal aging

  2010cited by this paper
• Larger temporal volume in elderly with high versus low beta-amyloid deposition.

  2010cited by this paper
• When does brain aging accelerate? Dangers of quadratic fits in cross-sectional studies

  2010cited by this paper
• Joint analysis of structural and perfusion MRI for cognitive assessment and classification of Alzheimer's disease and normal aging

  2010cited by this paper
• Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people.

  2010cited by this paper
• β-Amyloid burden in the temporal neocortex is related to hippocampal atrophy in elderly subjects without dementia

  2010cited by this paper
• Can Alzheimer disease be prevented by amyloid-β immunotherapy?

  2010cited by this paper
• P4‐070: Higher Amyloid Burden is Associated With Decreased Hippocampal and Parahippocampal Activation Across Two Functional Tasks in Healthy Older Adults

  2010cited by this paper
• Relationship between atrophy and β‐amyloid deposition in Alzheimer disease

  2010cited by this paper
• Inter-laboratory variation in cerebrospinal fluid biomarkers for Alzheimer's disease: united we stand, divided we fall

  2010cited by this paper
• Amyloid beta and APP as biomarkers for Alzheimer's disease.

  2010cited by this paper
• P2‐381: A tensor‐based morphometry study of brain volume changes in symptomatic and pre‐symptomatic patients with familial Alzheimer's disease

  2010cited by this paper
• Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade.

  2010cited by this paper
• Brain atrophy in healthy aging is related to CSF levels of Aβ1-42.

  2010cited by this paper
• Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease

  2009cited by this paper
• Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects.

  2009cited by this paper
• Amyloid precursor protein increases cortical neuron size in transgenic mice.

  2009cited by this paper
• Cognitive decline and brain volume loss as signatures of cerebral amyloid-beta peptide deposition identified with Pittsburgh compound B: cognitive decline associated with Abeta deposition.

  2009cited by this paper
• The Nun Study

  2009cited by this paper
• Synaptic contact number and size in stratum radiatum CA1 of APP/PS1DeltaE9 transgenic mice.

  2009cited by this paper
• Automated MRI measures identify individuals with mild cognitive impairment and Alzheimer's disease

  2009cited by this paper
• Decreased cerebrospinal fluid Aβ42 correlates with brain atrophy in cognitively normal elderly

  2009cited by this paper
• Cerebrospinal fluid tau and ptau181 increase with cortical amyloid deposition in cognitively normal individuals: Implications for future clinical trials of Alzheimer's disease

  2009cited by this paper
• Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

  2009cited by this paper
• Longitudinal regional brain volume changes quantified in normal aging and Alzheimer's APP x PS1 mice using MRI.

  2009cited by this paper
• The Cortical Signature of Alzheimer's Disease: Regionally Specific Cortical Thinning Relates to Symptom Severity in Very Mild to Mild AD Dementia and is Detectable in Asymptomatic Amyloid-Positive Individuals

  2008cited by this paper
• β‐amyloid burden is not associated with rates of brain atrophy

  2008cited by this paper
• 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment.

  2008cited by this paper
• Neuronal Hypertrophy in Asymptomatic Alzheimer Disease

  2008cited by this paper
• Accelerated age-related cortical thinning in healthy carriers of apolipoprotein E epsilon 4.

  2008cited by this paper
• Accelerated age-related cortical thinning in healthy carriers of apolipoprotein E ɛ4

  2008cited by this paper
• Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial.

  2008cited by this paper
• Resistance to Alzheimer's pathology is associated with nuclear hypertrophy in neurons.

  2007cited by this paper
• Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ42 in humans

  2006cited by this paper
• Amyloid load and cerebral atrophy in Alzheimer's disease: An 11C‐PIB positron emission tomography study

  2006cited by this paper
• An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest

  2006cited by this paper
• Effects of Aβ immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease

  2005cited by this paper
• Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B

  2004cited by this paper
• Neuropathological stageing of Alzheimer-related changes

  2004cited by this paper
• A unified approach for morphometric and functional data analysis in young, old, and demented adults using automated atlas-based head size normalization: reliability and validation against manual measurement of total intracranial volume

  2004cited by this paper
• Measuring the thickness of the human cerebral cortex from magnetic resonance images.

  2000cited by this paper
• Screening for dementia by memory testing

  1988cited by this paper

• Transfer learning from 2D natural images to 4D fMRI brain images via geometric mapping.

  2026cites this paper
• Neurobiological correlates of longitudinal grey matter volume changes in preclinical Alzheimer’s disease

  2025cites this paper
• Effects of a 24-week resistance exercise program on Alzheimer's disease brain signatures in cognitively normal older adults: results from the AGUEDA trial.

  2025cites this paper
• Modern biomarkers as key tools in the early diagnosis and monitoring of Alzheimer's disease progression

  2025cites this paper
• Soluble Aβ pathology predicts neurodegeneration and cognitive decline independently on p‐tau in the earliest Alzheimer's continuum: Evidence across two independent cohorts

  2025cites this paper
• Amnestic Transitional Cognitive Decline in Aging and Preclinical Alzheimer's Disease

  2025cites this paper
• Tracking a decade of structural changes in preclinical and prodromal Alzheimer’s disease: insights from amyloid-β pathology

  2025cites this paper
• Longitudinal association of shorter leukocyte telomere length with CSF biomarker dynamics across early Alzheimer's disease stages in at-risk individuals

  2025cites this paper
• Rates of cortical thinning in Alzheimer’s disease signature regions associate with vascular burden but not with β-amyloid status in cognitively normal adults at age 70

  2024cites this paper
• Association of β-Amyloid, Microglial Activation, Cortical Thickness, and Metabolism in Older Adults Without Dementia.

  2024cites this paper
• Alterations in Gray Matter Structural Networks in Amnestic Mild Cognitive Impairment: A Source-Based Morphometry Study

  2024cites this paper
• Cortical microstructural changes predict tau accumulation and episodic memory decline in older adults harboring amyloid

  2023cites this paper
• Annualized changes in rate of amyloid deposition and neurodegeneration are greater in participants who become amyloid positive than those who remain amyloid negative.

  2023cites this paper
• Neuroanatomical and neurocognitive changes associated with subjective cognitive decline

  2023cites this paper
• Seeing beyond the symptoms: biomarkers and brain regions linked to cognitive decline in Alzheimer’s disease

  2023cites this paper
• Differential effects of sleep on brain structure and metabolism at the preclinical stages of AD

  2023cites this paper
• Associations Between Sub-Threshold Amyloid-β Deposition, Cortical Volume, and Cognitive Function Modulated by APOE ɛ4 Carrier Status in Cognitively Normal Older Adults

  2022cites this paper
• APOE ε4 Allele Distribution and Association With Scores of Subjective Cognitive Decline Questionnaire 9 in a Large Chinese Memory Clinic Cohort

  2022cites this paper
• Impaired Ocular Tracking and Cortical Atrophy in Idiopathic Rapid Eye Movement Sleep Behavior Disorder

  2022cites this paper
• Brain alterations in the early Alzheimer’s continuum with amyloid-β, tau, glial and neurodegeneration CSF markers

  2022influential citation
• Longitudinal brain atrophy and CSF biomarkers in early-onset Alzheimer’s disease

  2021cites this paper
• Longitudinal brain atrophy and CSF biomarkers in early-onset Alzheimerâs disease

  2021cites this paper
• Association of Subjective Cognitive Decline with Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease Pathology in Cognitively Intact Older Adults: The CABLE Study

  2021cites this paper
• When Does Alzheimer's Disease Really Start? The Role of Biomarkers.

  2021cites this paper
• Is bigger better? Towards a mechanistic understanding of neuropsychiatric symptoms in Alzheimer’s disease

  2021cites this paper
• Salivary lactoferrin is associated with cortical amyloid-beta load, cortical integrity, and memory in aging

  2021cites this paper
• The relationship between white matter microstructure and self-perceived cognitive decline

  2021cites this paper
• Cognitively unimpaired individuals with a low burden of Aβ pathology have a distinct CSF biomarker profile

  2021cites this paper
• PIRACY: An Optimized Pipeline for Functional Connectivity Analysis in the Rat Brain

  2020cites this paper
• Structural imaging outcomes in subjective cognitive decline: Community vs. clinical-based samples.

  2020cites this paper
• Distinct effects of beta‐amyloid and tau on cortical thickness in cognitively healthy older adults

  2020cites this paper
• Biphasic cortical macro‐ and microstructural changes in autosomal dominant Alzheimer's disease

  2020cites this paper
• Synchronous nonmonotonic changes in functional connectivity and white matter integrity in a rat model of sporadic Alzheimer’s disease

  2020cites this paper
• Tracking Cortical Changes Throughout Cognitive Decline in Parkinson's Disease

  2020cites this paper
• Amyloid β influences the relationship between cortical thickness and vascular load

  2020cites this paper
• Cortical microstructural correlates of astrocytosis in autosomal-dominant Alzheimer disease

  2020cites this paper
• Spatio-temporal alterations in functional connectivity and white matter microstructure resulting from glucose hypometabolism in a rat model of sporadic Alzheimer’s disease

  2020cites this paper
• Diffusion MRI biomarkers of white matter microstructure vary nonmonotonically with increasing cerebral amyloid deposition.

  2020cites this paper
• Different Cortical Thinning Patterns Depending on Their Prognosis in Individuals with Subjective Cognitive Decline

  2019cites this paper
• CSF glial biomarkers YKL40 and sTREM2 are associated with longitudinal volume and diffusivity changes in cognitively unimpaired individuals

  2019cites this paper
• Increased Cortical Thickness in Attentional Networks in Parkinson's Disease with Minor Hallucinations

  2019cites this paper
• Associations among amyloid status, age, and longitudinal regional brain atrophy in cognitively unimpaired older adults.

  2019cites this paper
• Investigating the relationship between β-amyloid and grey matter macrostructure and microstructure in ageing and dementia

  2019cites this paper
• Biomarker-Based Signature of Alzheimer’s Disease in Pre-MCI Individuals

  2019cites this paper
• A multipredictor model to predict the conversion of mild cognitive impairment to Alzheimer’s disease by using a predictive nomogram

  2019cites this paper
• When Does Alzheimer′s Disease Really Start? The Role of Biomarkers

  2019cites this paper
• Associations Between the Subjective Cognitive Decline-Questionnaire’s Scores, Gray Matter Volume, and Amyloid-β Levels

  2019cites this paper
• Interaction effect of alcohol consumption and Alzheimer disease polygenic risk score on the brain cortical thickness of cognitively normal subjects.

  2019cites this paper
• Cerebrospinal fluid progranulin is associated with increased cortical thickness in early stages of Alzheimer's disease.

  2019cites this paper
• Regionally specific changes in the hippocampal circuitry accompany progression of cerebrospinal fluid biomarkers in preclinical Alzheimer's disease

  2018cites this paper
• Multimodal Imaging for Enhanced Diagnosis and for Assessing Progression of Alzheimer's Disease

  2018cites this paper
• Subjective Cognitive Decline and APOE ɛ4: A Systematic Review

  2018cites this paper
• Alzheimer’s Disease Biomarkers Have Distinct Associations with Specific Hippocampal Subfield Volumes

  2018cites this paper
• Cortical microstructural changes along the Alzheimer's disease continuum

  2018cites this paper
• Obesity and Alzheimer's disease, does the obesity paradox really exist? A magnetic resonance imaging study

  2018cites this paper
• The Rationale Behind the New Alzheimer’s Disease Conceptualization: Lessons Learned During the Last Decades

  2018cites this paper
• Cortical microstructure in young onset Alzheimer's disease using neurite orientation dispersion and density imaging

  2018cites this paper
• Subjective cognitive decline: preclinical manifestation of Alzheimer’s disease

  2018cites this paper
• Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets

  2018cites this paper
• Mechanisms of functional compensation, delineated by eigenvector centrality mapping, across the pathophysiological continuum of Alzheimer’s disease

  2018cites this paper
• Plasma amyloid-β levels, cerebral atrophy and risk of dementia: a population-based study

  2018cites this paper
• Cerebral changes and disrupted gray matter cortical networks in asymptomatic older adults at risk for Alzheimer's disease.

  2018cites this paper
• Inflammation, Amyloid, and Atrophy in The Aging Brain: Relationships with Longitudinal Changes in Cognition

  2017cites this paper
• Longitudinal brain structural changes in preclinical Alzheimer's disease

  2017cites this paper
• A Biphasic model for cortical structural changes in preclinical AD: a multimodal MRI, CSF and PET study /

  2017influential citation
• Interactive versus additive relationships between regional cortical thinning and amyloid burden in predicting clinical decline in mild AD and MCI individuals

  2017cites this paper
• Cerebrospinal Fluid Levels of Amyloid Beta 1-43 Mirror 1-42 in Relation to Imaging Biomarkers of Alzheimer’s Disease

  2017cites this paper
• Brain structural profile of multiple system atrophy patients with cognitive impairment

  2017cites this paper
• Weight loss in the healthy elderly might be a non-cognitive sign of preclinical Alzheimer's disease

  2017cites this paper
• Detectable Neuropsychological Differences in Early Preclinical Alzheimer’s Disease: A Meta-Analysis

  2017influential citation
• Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria

  2016cites this paper
• Revista Española de Geriatría y Gerontología

  2016cites this paper
• CSF YKL-40 and pTau181 are related to different cerebral morphometric patterns in early AD.

  2016cites this paper
• The Role of the Glycerophosphocholine Remodelling in Alzheimer’s Disease

  2016cites this paper
• Subjective cognitive impairment: Towards early identification of Alzheimer disease.

  2016cites this paper
• Brain CT and MRI: differential diagnosis of imaging findings.

  2016cites this paper
• Multimodal MRI Study of Human Brain Connectivity: Cognitive Networks

  2015cites this paper
• APOE effect on Alzheimer's disease biomarkers in older adults with significant memory concern

  2015cites this paper
• Evolving Evidence for the Value of Neuroimaging Methods and Biological Markers in Subjects Categorized with Subjective Cognitive Decline

  2015cites this paper
• Amyloid and Tau Biomarkers in Subjective Cognitive Impairment

  2015cites this paper
• APOE effect on Alzheimer's disease biomarkers in older adults with significant memory concern

  2015cites this paper
• Recommendations to standardize Pre-analytical confounding factors in Alzheimer ’ s and Parkinson ’ s disease CSF biomarkers : an update

  2015cites this paper
• APOE effect on Alzheimer’s biomarkers in older adults with significant memory concern

  2015cites this paper
• Mapping the Relationship of Contributing Factors for Preclinical Alzheimer’s Disease

  2015cites this paper
• Evolving brain structural changes in PSEN1 mutation carriers.

  2015cites this paper
• Nonlinear cerebral atrophy patterns across the Alzheimer's disease continuum: impact of APOE4 genotype.

  2015cites this paper
• Title : CSF ß-amyloid and phospho-tau biomarker interactions on brain structure in preclinical

  2014cites this paper
• Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria.

  2014cites this paper
• Cerebrospinal fluid β‐amyloid and phospho‐tau biomarker interactions affecting brain structure in preclinical Alzheimer disease

  2014cites this paper
• What is normal in normal aging? Effects of aging, amyloid and Alzheimer's disease on the cerebral cortex and the hippocampus.

  2014cites this paper
• Subjective Cognitive Impairment Subjects in Our Clinical Practice

  2014cites this paper
• White matter changes in preclinical Alzheimer's disease: a magnetic resonance imaging-diffusion tensor imaging study on cognitively normal older people with positive amyloid β protein 42 levels.

  2014cites this paper
• A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease

  2014cites this paper
• Neural correlates of minor hallucinations in non-demented patients with Parkinson's disease.

  2014cites this paper
• Cognitive and Neuroimaging Profiles in Mild Cognitive Impairment and Alzheimer's Disease: Data from the Spanish Multicenter Normative Studies (NEURONORMA Project)

  2014cites this paper
• Longitudinal gray-matter volume change in the default-mode network: utility of volume standardized with global gray-matter volume for Alzheimer’s disease: a preliminary study

  2014cites this paper
• Cerebrospinal fluid biomarkers of Alzheimer's disease in healthy elderly.

  2013cites this paper
• Pattern of Regional Cortical Thinning Associated with Cognitive Deterioration in Parkinson’s Disease

  2013cites this paper
• The role of apolipoprotein E (APOE) genotype in early mild cognitive impairment (E-MCI)

  2013cites this paper
• Cognitive Reserve Proxies Relate to Gray Matter Loss in Cognitively Healthy Elderly with Abnormal Cerebrospinal Fluid Amyloid-β Levels

  2013cites this paper